SUSTAIN 340B Act
Latest action (5 Aug 2026): Introduced
What this bill does
S. 5244 would amend the Public Health Service Act's provisions governing the 340B drug discount program, though the specific changes it would make are not yet available in the published bill text. Since the bill was introduced on 2026-08-05 without accompanying legislative text, only its title, sponsor, and status are currently known.
The 340B program allows certain hospitals and other healthcare providers serving low-income or vulnerable populations to purchase outpatient drugs from manufacturers at reduced prices. Because the bill's specific provisions are not yet public, it is not possible to say which participants — providers, drug manufacturers, or patients — would be affected or how, until the full text is released.
The bill was introduced in the Senate on 2026-08-05 by Sen. Jerry Moran (R-KS) and referred to committee, which is the standard next step for a newly introduced bill. Its current status is "Introduced," meaning it has not yet been scheduled for a committee vote, floor vote, or further action. Further progress — including release of the full bill text, committee consideration, and possible amendments — would need to occur before its effects can be assessed in detail.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill is in the first stage of the legislative process. It was introduced into Congress on August 5, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.
Common questions
- What does S. 5244 do?
- S. 5244 would amend the Public Health Service Act's provisions governing the 340B drug discount program, though the specific changes it would make are not yet available in the published bill text. Since the bill was introduced on 2026-08-05 without accompanying legislative text, only its title, sponsor, and status are currently known. The 340B program allows certain hospitals and other healthcare providers serving low-income or vulnerable populations to purchase outpatient drugs from manufacturers at reduced prices. Because the bill's specific provisions are not yet public, it is not possible to say which participants — providers, drug manufacturers, or patients — would be affected or how, until the full text is released. The bill was introduced in the Senate on 2026-08-05 by Sen. Jerry Moran (R-KS) and referred to committee, which is the standard next step for a newly introduced bill. Its current status is "Introduced," meaning it has not yet been scheduled for a committee vote, floor vote, or further action. Further progress — including release of the full bill text, committee consideration, and possible amendments — would need to occur before its effects can be assessed in detail.
- Has S. 5244 become law?
- Not yet. As of 5 Aug 2026, S. 5244 is introduced.
- Who sponsored S. 5244?
- S. 5244 was sponsored by Sen. Jerry Moran [R-KS] (Republican-KS), with 5 cosponsors.
- What's the latest action on S. 5244?
- Introduced (5 Aug 2026).
Related bills in Health
Expressing support for the designation of September 22, 2026, as “National Hispanic Nurses Day” and recognizing the National Association of Hispanic Nurses as the leading organization representing and advocating for Hispanic nurses.
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Community Health Worker Access Act
A resolution supporting the designation of October 2026 as “Substance Use & Misuse Prevention Month” to raise awareness of substance use and misuse in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.